Protective Immunity Elicited by VP1 Chimeric Antigens of Bacterial Ghosts against Hand-Foot-and-Mouth Disease Virus

This study was designed to evaluate the immunogenicity and protective efficacy of two VP1 chimeric antigens of bacterial ghosts. Inoculation of the two VP1 chimeric antigens of bacterial ghosts into BALB/c mice markedly elicited humoral and mucosal immune responses. The specific antibodies induced by the chimeric ghosts protected mice not only against the virus that causes hand-foot-and-mouth disease but also against E. coli O157:H7 bacterial infection. In comparison with the negative control, immunization with the chimeric ghosts protected mice against two LD50 hand-foot-and-mouth disease viral infection. In addition, this specific immunity also protected the pups of pregnant mice immunized with the VP1 chimeric antigens of bacterial ghosts against 20 MLD E. coli O157:H7 infection. Taken together, the results of this study verify for the first time that the VP1 chimeric antigens of bacterial ghosts are target candidates for a new type of vaccine against hand-foot-and-mouth disease. Additionally, this vaccine strategy also elicited a stronger immune response against E. coli O157:H7.

[1]  Tao Li,et al.  VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment , 2019, Front. Immunol..

[2]  Wenhai Yu,et al.  Correction: A Novel Neutralizing Antibody Specific to the DE Loop of VP1 Can Inhibit EV-D68 Infection in Mice , 2019, The Journal of Immunology.

[3]  Juine-Ruey Chen,et al.  The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus , 2019, PloS one.

[4]  Wenyan Zhang,et al.  Understanding the epidemiological characteristics of EV71 and CVA16 infection to aid the diagnosis and treatment of hand, foot, and mouth disease , 2018, Journal of medical virology.

[5]  Hui Yang,et al.  Design and immune characterization of a novel Neisseria gonorrhoeae DNA vaccine using bacterial ghosts as vector and adjuvant. , 2018, Vaccine.

[6]  Li-Min Huang,et al.  Fibroblast-stimulating lipopeptide-1 as a potential mucosal adjuvant enhances mucosal and systemic immune responses to enterovirus 71 vaccine. , 2018, Vaccine.

[7]  Kun Cai,et al.  Novel fusion antigen displayed-bacterial ghosts vaccine candidate against infection of Escherichia coli O157:H7 , 2015, Scientific Reports.

[8]  P. Pathinayake,et al.  Innate Immunity and Immune Evasion by Enterovirus 71 , 2015, Viruses.

[9]  P. Chong,et al.  Review of enterovirus 71 vaccines. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Qinjian Zhao,et al.  Protection against Lethal Enterovirus 71 Challenge in Mice by a Recombinant Vaccine Candidate Containing a Broadly Cross-Neutralizing Epitope within the VP2 EF Loop , 2014, Theranostics.

[11]  N. Crawford,et al.  EV71 vaccine: protection from a previously neglected disease , 2013, The Lancet.

[12]  I. Su,et al.  CD4 T-Cell-Independent Antibody Response Reduces Enterovirus 71 Lethality in Mice by Decreasing Tissue Viral Loads , 2012, Clinical & developmental immunology.

[13]  H. Liu,et al.  Intragastric immunization of mice with enterohemorrhagic Escherichia coli O157:H7 bacterial ghosts reduces mortality and shedding and induces a Th2-type dominated mixed immune response. , 2010, Canadian journal of microbiology.

[14]  Z. Sekawi,et al.  DNA vaccine constructs against enterovirus 71 elicit immune response in mice , 2007, Genetic vaccines and therapy.

[15]  W. Lubitz,et al.  Bacterial ghosts as adjuvant particles , 2007, Expert review of vaccines.

[16]  A. Hofmann,et al.  Comparative immunogenicity of the hepatitis B virus core 149 antigen displayed on the inner and outer membrane of bacterial ghosts. , 2005, Vaccine.

[17]  V. DelVecchio,et al.  Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors , 2004, Expert review of vaccines.

[18]  W. Lubitz,et al.  Bacterial Ghosts Are an Efficient Delivery System for DNA Vaccines1 , 2004, The Journal of Immunology.

[19]  V. Kutyrev,et al.  Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits. , 2003, Vaccine.

[20]  M. Rohde,et al.  Generation of Helicobacter pylori Ghosts by PhiX Protein E-Mediated Inactivation and Their Evaluation as Vaccine Candidates , 2003, Infection and Immunity.

[21]  A. Hensel,et al.  Endotoxicity does not limit the use of bacterial ghosts as candidate vaccines. , 1997, Vaccine.

[22]  F. Jähnig,et al.  Refolding of an integral membrane protein. OmpA of Escherichia coli. , 1990, The Journal of biological chemistry.

[23]  F. Jähnig,et al.  Restoration of membrane incorporation of an Escherichia coli outer membrane protein (OmpA) defective in membrane insertion. , 1989, The Journal of biological chemistry.

[24]  W. Lubitz,et al.  Biochemical characterization of phi X174-protein-E-mediated lysis of Escherichia coli. , 1989, European journal of biochemistry.

[25]  G. Hobom,et al.  Materials and Methods Bacterial Strains , Virus Strains , cDNA Clones , and Media , 2005 .

[26]  H. Khorana,et al.  Refolding of an integral membrane protein. Denaturation, renaturation, and reconstitution of intact bacteriorhodopsin and two proteolytic fragments. , 1981, The Journal of biological chemistry.

[27]  J. Nam,et al.  A peptide vaccine based on a B-cell epitope on the VP1 protein of enterovirus 70 induces a strong antibody response. , 2012, Acta virologica.

[28]  W. Lubitz,et al.  Dynamics of PhiX174 protein E-mediated lysis of Escherichia coli , 2004, Archives of Microbiology.